Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 62 results for "novartis"

Novartis India standalone net profit declines 63.14% in the Ju...

Sales decline 32.98% to Rs 114.81 crore Business Standard, 3 weeks ago
Novartis India to announce quarterly results Business Standard, 1 month ago
Novartis India fixes record date for dividend Business Standard, 1 month ago

228 images for novartis

Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 1 month ago
Reuters, 2 months ago
Reuters, 2 months ago
Reuters, 3 months ago
Business Standard, 3 months ago
DNA, 3 months ago
Reuters, 3 months ago
Reuters, 4 months ago
Money Control

Novartis India: Outcome of AGM

Please find enclosed a summary of the proceedings of the 69th Annual General Meeting of the Company held on July 28, 2017 in Mumbai.
 Money Control3 weeks ago Novartis India#39;s board meeting on July 27, 2017  Money Control1 month ago

Novartis India drops after weak Q1 result

Novartis India lost 2.82% to Rs 641.95 at 09:16 IST on BSE after net profit dropped 63.14% to Rs 7.03 crore on 32.98% decrease in net sales to Rs 114.81 crore in Q1 June 2017 over Q1 June 2016.
 Business Standard3 weeks ago Board of Novartis India recommends final dividend  Business Standard2 months ago Novartis India drops after weak Q4 earnings  Business Standard2 months ago

Drug giants hunt for Indian patients

Global pharmaceutical companies, from Indianapolis-based Eli Lilly & Co. to Switzerland’s Novartis AG, are heading into smaller cities and rural areas.
 MSN India2 weeks ago
Money Control

Novartis India Q1 net profit down 63 pc at Rs 7 cr

Drug firm Novartis India today reported a 63.13 per cent decline in its net profit to Rs 7.03 crore for the quarter ended June 30, mainly impacted by down stocking in trade channels due to GST. The company had posted a net profit of Rs 19.07 crore for the ...
 Business Standard3 weeks ago

Price fixation of essential drugs hits profitability: Novartis

The fixation of ceiling prices of essential drugs by the pharma pricing regulator NPPA has impacted the profitability of the company, drug firm Novartis India has said.
 DNA1 month ago

Sales hopes for new Novartis, Merck heart drugs under microscope

Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as to whether this scientific success will translate into blockbuster sales. Detailed data on both Novartis's ...
 Reuters1 month ago

Novartis, IBM Watson Health team up for breast cancer project

Novartis has agreed to work with IBM Watson Health to explore ways to use patient data and advanced analysis to glean insights on the likely outcomes of breast cancer treatments, the Swiss drugmaker said on Monday. "Through this collaboration with IBM Watson ...
 Reuters2 months ago

Novartis CEO sees no need for big takeover

Joe Jimenez, the CEO of Swiss pharmaceutical company Novartis AG, addresses a news conference to present the company's 2016 results in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann 1/2 left right The logo of Swiss drugmaker Novartis is seen at ...
 Reuters2 months ago

A revolutionary gene therapy leukaemia treatment could soon be approved

CTL019 is custom-made, personalised drug developed by University of Pennsylvania and Novartis
 Business Standard1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less